NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis



Research conducted by J.Y. Chen and co-researchers has updated our knowledge about tuberculosis



June 9th, 2009

"A 24-year-old man suffering from end-stage, multi-drug, resistant tuberculosis and right heart failure underwent bilateral, single-lung transplantation with extracorporeal membrane oxygenator support," scientists writing in the journal Annals of Thoracic Surgery report.

"He was successfully weaned and discharged from the hospital 30 days later. Sputum cultures have been negative for tuberculosis since discharge, and for almost 2 years thereafter," wrote J.Y. Chen and colleagues.

The researchers concluded: "Anti-tuberculosis medication was discontinued 4 months postoperatively."

Chen and colleagues published their study in...


Source: TB & Outbreaks Week (2009-06-09)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login